These are the three most common cancers of the urinary system. Kidney cancer starts in the kidney's filtering cells, prostate cancer in the gland below a man's bladder, and bladder cancer in the bladder's lining. Many cases today can be treated with organ-preserving approaches that remove the tumour while keeping the healthy organ intact.
Prostate cancer: about 1 in 8 men will be diagnosed in their lifetime, making it the most common cancer in men besides skin cancer (American Cancer Society). Kidney cancer is about twice as common in men as women. Bladder cancer is roughly 4 times more common in men than women.
Causes & risk factors
- Smoking — a major risk factor for bladder cancer, and linked to kidney cancer too
- Age — risk rises sharply after 50–65 across all three cancers
- Family history/genetics (e.g. BRCA, Lynch syndrome)
- Obesity and high blood pressure, linked to kidney cancer
- Chronic bladder irritation or certain chemical/industrial exposures
- Race — prostate cancer is more common and more aggressive in Black men
Symptoms to watch for
- Blood in the urine, visible or microscopic — present in most bladder and many kidney cancers
- Persistent flank/back pain or a lump in the abdomen (kidney cancer)
- Difficulty urinating or a weak stream (prostate cancer — often no symptoms in early stages)
- Unexplained weight loss or fatigue
- Painful urination or frequent UTIs (bladder cancer)
How it's diagnosed
- PSA blood test and digital rectal exam (prostate)
- Urine cytology and cystoscopy (bladder)
- CT/MRI imaging (kidney, and staging for all three)
- Biopsy for tissue diagnosis
- Bone/CT scans for staging once cancer is confirmed
Treatment options
- Active surveillance: monitoring low-risk prostate cancer without immediate treatment.
- Partial nephrectomy: removes only the kidney tumour, preserving kidney function — 90–100% cancer-specific survival for small tumours.
- TURBT ± trimodal therapy: scrapes out a bladder tumour, then combines chemotherapy and radiation to preserve the bladder instead of removing it.
- Robotic/laparoscopic surgery: minimally invasive removal of kidney and prostate tumours.
- Radiation therapy: external beam or seed implants, an organ-preserving alternative to surgery.
- Immunotherapy/targeted therapy: for advanced or metastatic disease.
Outlook & prevention
Survival has improved markedly — the prostate cancer death rate has fallen about 50% since 1993 (American Cancer Society), largely due to earlier detection and organ-preserving treatment. Quitting smoking is the single biggest modifiable step to lower bladder and kidney cancer risk, and prompt evaluation of blood in urine allows earlier, more treatable diagnosis.
- Any blood in the urine, even a single episode
- Unexplained flank pain, pelvic pain, or a new abdominal lump
- Urinary difficulty or new lower urinary tract symptoms after age 50